IL10 and colitis: In this study, we explored the underlying mechanism by which intraperitoneally delivered MSCs alleviated colitis and found that MSC-derived THBS1 could boost IL-10-producing B cells through THBS1-mediated TGF-β activation, thereby suppressing colon inflammation and preventing the recurrence of colitis.